Concepedia

Concetta Ferracane

CF

Statistics

Publications

11

Citations

236

H-Index

11

Active since

2018

Affiliations

Ospedale Vincenzo Cervello(Current)

Azienda Ospedaliera Universitaria Policlinico "G. Martino"

Ospedale Cannizzaro

Azienda Ospedaliero-Universitaria Policlinico - Vittorio Emanuele

Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone" di Palermo

Concetta Ferracane is an author at Ospedale Vincenzo Cervello specializing in medicine, gastroenterology, and rheumatoid arthritis.

Top concepts

Publications per year

2018–2023

11

Publications

11

The real-world effectiveness of vedolizumab on intestinal and articular outcomes in inflammatory bowel diseases

Fabio Salvatore Macaluso, Rosalba Orlando, Walter Fries et al. · Digestive and Liver Disease · 2018 · 42 citations

, , +8

A Propensity Score-matched Comparison of Infliximab and Adalimumab in Tumour Necrosis Factor-α Inhibitor-naïve and Non-naïve Patients With Crohn’s Disease: Real-Life Data From the Sicilian Network for Inflammatory Bowel Disease

Fabio Salvatore Macaluso, Walter Fries, A Privitera et al. · Journal of Crohn s and Colitis · 2018 · 34 citations

A propensity score weighted comparison of Vedolizumab, Adalimumab, and Golimumab in patients with ulcerative colitis

Fabio Salvatore Macaluso, Marco Ventimiglia, Walter Fries et al. · Digestive and Liver Disease · 2020 · 24 citations

, , +4

Ustekinumab in Crohn's disease: Real‐world outcomes from the Sicilian network for inflammatory bowel diseases

Anna Viola, Marco Muscianisi, Fabio Salvatore Macaluso et al. · JGH Open · 2021 · 22 citations · Full text

SPOSAB ABP 501: A Sicilian Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Adalimumab Biosimilar ABP 501

Fabio Salvatore Macaluso, Maria Cappello, Anita Busacca et al. · Journal of Gastroenterology and Hepatology · 2021 · 21 citations

1–5 of 11